Innovative Strategies to Improve Patient Access
Technology advancements in recent years have created many opportunities for improving patient access, including opportunities for self-scheduling. As practices are investing significant resources in this space it is important to understand the challenges, limitations, and impacts of these innovative approaches to solving patient access issues.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cost $0.00
Reducing Intersectional Stigmas to Improve Outcomes in People Impacted by Cancer
Intersectional stigmas in cancer care can exacerbate disparities by compounding the challenges faced by individuals who belong to multiple marginalized groups, leading to inequities in access, treatment, and outcomes. There is often a lack of consistent implementation of screening and support services that address the unique needs of marginalized patients, resulting in disparities in early detection, treatment, and follow-up care.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
Preparing the Oncology Nursing Workforce: Innovative Strategies and Partnerships
With the increasing complexity of cancer care and the growing population of cancer patients, the need for skilled oncology nurses is more crucial than ever. Ensuring that oncology nurses are equipped with the necessary skills and knowledge is essential for providing high-quality care and improving patient outcomes.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cost $0.00
From Theory to Practice: Building Sustainable, High-Impact Patient Navigation Models
Patient navigation is highly variable; therefore, it is important to understand the factors that contribute to program success. It is also timely given the expansion of reimbursement for these types of services, as programs are looking at the sustainability of their programs and examining ways to better build or refine existing services.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cost $0.00
Effective and Safe Telehealth Delivery and Remote Patient Monitoring
In a continuous effort to provide cost-effective, high-quality oncology care, varying degrees of telehealth delivery and remote patient monitoring are being piloted or have been implemented. Exploring this topic is a valuable exercise to help the oncology care team know what is currently being done and what is on the horizon.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cost $0.00
New Tools for Breast Cancer Risk Assessment
It is important for clinicians to learn about these risk assessment models, understand their limitations and benefits, and determine the best breast cancer risk reduction strategy that can be used for an individual.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
Cost $0.00
Updates in the Management of Biliary Tract Cancers
The advent of novel targeted agents has led to a shift in the treatment paradigm of advanced biliary tract cancers. In recent years, multiple targeted agents were FDA-approved, including tumor-agnostic agents. As such, molecular profiling has become increasingly useful and can potentially help guide treatment decisions.
Category
  • Hepatobiliary Cancers
Format
  • Recorded Webcast
Credits
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
Cost $0.00
Treatment for Pleural and Peritoneal Mesothelioma
Recent phase 3 clinical trial data suggest that surgery and chemotherapy may lead to worse survival outcomes than chemotherapy alone for certain patients with pleural mesothelioma. Additionally, data on other systemic therapy regimens for the treatment of mesothelioma have been recently published.
Category
  • Mesothelioma
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
Advances in the Treatment of Non-Metastatic Non-Small Cell Lung Cancer
Clinicians should be aware of all the available systemic therapy regimens as well as updated guideline recommendations on biomarker testing and treatment to ensure that patients with non-metastatic NSCLC receive the most appropriate treatments.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cost $0.00
Newer Approaches to Treatment of Bladder Cancer
Recent approvals and clinical trial results continue to enhance treatment options for both BCG-resistant non-muscle invasive bladder cancer and locally advanced/metastatic bladder cancer. Clinicians should be knowledgeable in these recent updates as well as understand how to apply them to their clinical practice.
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cost $0.00

Pages